Search

Artificial Intelligence (AI) in telemedicine, enabling continuity of healthcare services,

The concept of “Pet Humanization”, or treating pets as children or family members, has become increasingly widespread.

Thailand’s pharmaceutical industry is expected to expand during 2026–2028, driven by population aging, the rising prevalence of non-communicable diseases (NCDs), and broader access to healthcare

In 2020 operating results of private hospitals have been under pressure from the COVID-19 epidemic, affecting purchasing power of Thai and foreign patients

The pharmaceuticals industry will enjoy favorable business conditions through the next three years with the forecast 6.0-7.0% annual growth in the domestic sales value in 2025-2027. Sales will be lifted by an expansion in case numbers for non-communicable diseases (NCDs) and infections with notifiable conditions, growth in emerging and reemerging diseases

Opportunities for Financial Institutions in Vietnam Adaptation Amid Macroeconomic and Financial Risks

Industry Horizon January 2025

The value of the domestic market for pharmaceuticals is expected to grow by 4.5-5.0% in 2022 relative to the 2021 figure, thanks to the easing of fears about COVID-19 and the return of the Thai economy to somewhere close to its normal level, with the subsequent rebound in growth then feeding into stronger spending power. Over 2023 to 2025, the market is expected to continue to grow thanks to the likely ongoing rise in incidences of chronic non-communicable diseases (NCDs), the extension of universal health coverage programs to cover the whole of the Thai population, the increasing number of foreign patients seeking treatment in Thai hospitals,

Domestic demand for medical devices has continued to grow through 2025, driven in part by intermittent outbreaks of notifiable diseases and air pollution-related diseases